Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition: Multidrug Resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pyrazinamide; Drug: Linezolid; Drug: Cycloserine; Drug: Clofazimine Sponsor: Huashan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials